• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化经验性万古霉素给药算法,以提高热烧伤患者的目标浓度达标率。

Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.

机构信息

Firefighters Burn Center, Clinical Pharmacist, Department of Pharmacy, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA; Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee Health Science Center, 881 Madison Ave, Memphis, TN 38163, USA.

Department of Plastic Surgery, Firefighters Regional Burn Center, Regional One Health, 877 Jefferson Avenue, Memphis, TN 38103, USA; Department of Plastic Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

出版信息

Burns. 2019 Mar;45(2):423-432. doi: 10.1016/j.burns.2018.09.025. Epub 2018 Oct 16.

DOI:10.1016/j.burns.2018.09.025
PMID:30340863
Abstract

OBJECTIVE

Vancomycin empirical dosing studies in thermally injured patients have netted low successful target attainment and most excluded renal dysfunction, limiting applicability. In a previous study, the authors performed a retrospective analysis of 124 patients' measured pharmacokinetic parameters to calculate optimal dose and interval for intermittent infusion regimens and find predictors of clearance and total daily dose. The objective of this study was to improve the accuracy of attaining goal therapeutic targets with initial vancomycin regimens in patients with thermal injury through retrospective modeling.

METHODS

In this phase 2 study, variables collected and calculated regimens in phase 1 were utilized to try and create an improved empiric vancomycin dosing algorithm in patients with thermal injury. Logistic regression was utilized to determine best predictors of dosing vancomycin every 6 and 8h. The strongest models were built as individual algorithms and tested for accuracy of target attainment. Each algorithm produced a regimen for each patient that was then tested utilizing each patient's actual measured pharmacokinetic parameters.

RESULTS

Univariable logistic regression of 41 variables identified 27 and 23 to be predictive of dosing every 8 or 6h, respectively. The most predictive multivariable model for dosing every 8h consisted of creatinine clearance (CrCl)≥80ml/min, Acute Kidney Injury Network classification <1, and total body surface area burned≥10 percent. For dosing every 6h, CrCl≥80ml/min, age≤40years old, days since injury≤6, and serum creatinine (SCr)≤0.8 were most predictive. Based on the top 5 multivariable models for each dosing interval, 7 algorithms were built to produce recommended regimens. The highest performing algorithm resulted in trough concentrations of <10mg/L (23%), 10-20mg/L (65%), 15-20mg/L (26%), and >20mg/L (11%); area under the concentration curve (AUC)>400mghr/L (83%); and AUC >400mghr/L without having a trough >20mg/L (72%).

CONCLUSIONS

The algorithm that resulted in the highest target attainment without overdosing recommended 15mg/kg dosed every 24h for CrCl≥30, every 12h for CrCl 31-79, every 8h for patients with CrCl≥80ml/min, and every 6h only if the patient with a CrCl≥80ml/min is also≤40 years old and has a SCr≤0.8. Caution is warranted for groups underrepresented in this study, such as those with very low CrCl, a low BMI, or receiving renal replacement therapy. This algorithm should be validated in other centers for patients with thermal injuries.

摘要

目的

对烧伤患者进行万古霉素经验性给药研究的结果显示,大多数患者的目标药物浓度达标率较低,且这些研究大多排除了肾功能障碍患者,这限制了其适用性。在之前的一项研究中,作者对 124 名患者的药代动力学参数进行了回顾性分析,以计算间歇输注方案的最佳剂量和间隔,并发现了清除率和总日剂量的预测因子。本研究的目的是通过回顾性建模来提高烧伤患者初始万古霉素治疗方案达到目标治疗效果的准确性。

方法

在这项 2 期研究中,利用第 1 阶段收集和计算的方案,尝试为烧伤患者建立一种改进的经验性万古霉素给药算法。利用逻辑回归确定每 6 小时和 8 小时给药的最佳预测因子。将最强的模型构建为单独的算法,并测试其目标药物浓度达标率。为每个患者生成一个方案,然后利用每个患者的实际药代动力学参数对该方案进行测试。

结果

对 41 个变量进行单变量逻辑回归分析,分别有 27 个和 23 个变量可预测每 8 小时或 6 小时给药。预测每 8 小时给药的最佳多变量模型包括肌酐清除率(CrCl)≥80ml/min、急性肾损伤网络分类<1 和总体表烧伤面积≥10%。预测每 6 小时给药的最佳模型为 CrCl≥80ml/min、年龄≤40 岁、伤后时间≤6 天和血清肌酐(SCr)≤0.8。基于每个给药间隔的前 5 个多变量模型,构建了 7 种算法以生成推荐方案。性能最高的算法可使谷浓度<10mg/L(23%)、10-20mg/L(65%)、15-20mg/L(26%)和>20mg/L(11%);浓度-时间曲线下面积(AUC)>400mghr/L(83%);且 AUC>400mghr/L 而谷浓度不超过 20mg/L(72%)。

结论

该算法的目标药物浓度达标率最高,且不会过量用药,建议 CrCl≥30 时每 24 小时 15mg/kg 给药,CrCl 为 31-79 时每 12 小时给药,CrCl≥80ml/min 时每 8 小时给药,CrCl≥80ml/min 且年龄≤40 岁且 SCr≤0.8 时每 6 小时给药。对于本研究中代表性不足的人群,如 CrCl 非常低、BMI 较低或接受肾脏替代治疗的患者,应谨慎使用。该算法应在其他中心的烧伤患者中进行验证。

相似文献

1
Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.优化经验性万古霉素给药算法,以提高热烧伤患者的目标浓度达标率。
Burns. 2019 Mar;45(2):423-432. doi: 10.1016/j.burns.2018.09.025. Epub 2018 Oct 16.
2
Characterization of variables for potential impact on vancomycin pharmacokinetics in thermal or inhalation injury.热损伤或吸入性损伤中对万古霉素药代动力学可能产生影响的变量特征分析。
Burns. 2018 May;44(3):658-664. doi: 10.1016/j.burns.2017.10.004. Epub 2017 Oct 31.
3
The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.肌酐清除率上限对颅脑创伤合并神经危重症患者实现治疗性万古霉素浓度的影响。
Neurocrit Care. 2019 Feb;30(1):126-131. doi: 10.1007/s12028-018-0583-z.
4
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.胱抑素 C 指导下的危重症患者万古霉素剂量调整:一项质量改进项目。
Am J Kidney Dis. 2017 May;69(5):658-666. doi: 10.1053/j.ajkd.2016.11.016. Epub 2017 Jan 25.
5
First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.首剂量万古霉素药代动力学与重症患者基于 AUC 目标的经验性给药。
Pharmacotherapy. 2020 Dec;40(12):1210-1218. doi: 10.1002/phar.2486. Epub 2020 Dec 11.
6
The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.万古霉素持续静脉输注给药的药代动力学/药效学原理。
J Clin Pharm Ther. 2015 Jun;40(3):259-65. doi: 10.1111/jcpt.12270. Epub 2015 Apr 11.
7
Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy.儿童连续性肾脏替代治疗中万古霉素的群体药代动力学分析。
Eur J Clin Pharmacol. 2019 Aug;75(8):1089-1097. doi: 10.1007/s00228-019-02664-7. Epub 2019 Apr 1.
8
Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients.肥胖和极度肥胖患者真实世界队列中万古霉素给药的考量
Pharmacotherapy. 2015 Sep;35(9):869-75. doi: 10.1002/phar.1625. Epub 2015 Sep 6.
9
Optimal vancomycin dosing regimens for critically ill patients with acute kidney injury during continuous renal replacement therapy: A Monte Carlo simulation study.连续肾脏替代治疗期间急性肾损伤危重症患者的万古霉素最佳给药方案:蒙特卡罗模拟研究。
J Crit Care. 2019 Dec;54:77-82. doi: 10.1016/j.jcrc.2019.07.008. Epub 2019 Jul 10.
10
Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.肥胖脓毒症或感染性休克患者的万古霉素药代动力学。
Pharmacotherapy. 2020 Mar;40(3):211-220. doi: 10.1002/phar.2367. Epub 2020 Feb 5.

引用本文的文献

1
Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study.影响烧伤患者万古霉素谷浓度的因素:一项单中心回顾性研究
Front Pharmacol. 2024 Dec 12;15:1377930. doi: 10.3389/fphar.2024.1377930. eCollection 2024.